Lymphatic surgery for Alzheimer's patients
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a surgery called lymphaticovenular anastomosis (LVA) that aims to improve brain drainage in people with Alzheimer's disease. It may help by clearing waste proteins from the brain, potentially slowing the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of Alzheimer's disease from a neurologist and psychiatrist.
- A special brain scan (amyloid-PET) shows amyloid plaques, a hallmark of Alzheimer's.
- You are 18 years or older and can give consent, or have a legal representative who can.
- You have not had neck lymph node surgery, nasopharyngeal surgery, or brain surgery before.
- You do not have thyroid disease, chronic heart failure, or severe heart/lung problems that make anesthesia risky.
- You are not allergic to shellfish, iodine, or any anesthetic drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a surgery that connects tiny lymph vessels to veins in the neck area to help drain waste from the brain. It aims to see if this surgery can improve symptoms of Alzheimer's disease and understand how it works.
This study tests a surgical procedure to connect lymph vessels in the neck to veins, which may help clear waste from the brain in people with mild cognitive impairment or mild to moderate Alzheimer's disease. It is for patients who have not improved after at least 3 months of standard care.
This study tests a surgery called lymphaticovenous anastomosis (LVA) as a possible treatment for Alzheimer's disease. The surgery connects tiny lymph vessels to veins to help clear waste from the brain.
This trial tests a surgery that connects lymph vessels in the neck to help clear waste from the brain, which may slow down memory loss in people with moderate Alzheimer's disease. It is for patients who have not improved with standard medications.
This trial tests a procedure to improve the brain's waste-clearing system, which may slow the effects of Alzheimer's disease. It's a new approach that aims to help the brain work better.
This trial tests a surgery that targets the lymphatic system in the neck to help people with moderate-to-severe Alzheimer's disease. The goal is to see if it can improve cognitive function.
Hear when a new Alzheimer's Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.